Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intravesical BCG and Gemcitabine on Semen Quality and Testicular Volume in NMIBC
NCT05701332Phase 4Completed
- Sponsor
- Assiut University
- Start
- Apr 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine, gemcitabine in non-muscle-invasive bladder cancer (NMIBC), sponsored by Assiut University. Started Apr 2023; status: completed.
02
Drugs
bcg vaccinegemcitabine
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT05701332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05701332.